Tag: Diabetes: Type II
Reduced Endothelium-Dependent Vasodilation in T2DM
Vasodilator response to acetylcholine lower in patients with diabetes with and without neuropathy
Metformin Use Linked to Less Vitamin B12 Measurement
Metformin users are less likely to receive vitamin B12 testing after adjustment for confounding variables
Liraglutide May Blunt Impact of Exercise in Dysregulated T2DM
Improvement in early diastolic myocardial tissue velocity in placebo, not liraglutide group
Bariatric Surgery Tied to T2DM Resolution in Obese Patients
Surgery plus intensive medical therapy found more effective than intensive medical therapy alone
Dulaglutide Linked to Higher Adherence in T2DM
Higher adherence, lower discontinuation versus exenatide once weekly or liraglutide
Lixisenatide Beneficial in Seniors With Uncontrolled Diabetes
Improved HbA1c reduction versus placebo in older patients uncontrolled on current medications
Similar Metabolic Response to Animal, Plant Protein Diets
Similar improvements of metabolism and CV risk factors in T2DM with isocaloric diets
Ambient Air Pollution May Raise T2DM Risk in Hispanic Children
Study of obese Hispanic children suggests smog may increase odds of developing type 2 diabetes
Novel Oral Glucose Lowering Drugs Cut Risks in T2DM
Reduced risk of all-cause mortality and CVD with dapagliflozin; lower risk of mortality with DPP-4i
Review: Smokeless Tobacco Linked to Increased Risk of T2DM
Findings from five pooled cohorts show risk up with each additional box of snus consumed per week
